<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03305081</url>
  </required_header>
  <id_info>
    <org_study_id>IRBNet ID 628424-1</org_study_id>
    <nct_id>NCT03305081</nct_id>
  </id_info>
  <brief_title>Patient Compliance With Long-Acting Reversible Contraception Administration</brief_title>
  <official_title>Patient Compliance With Long-Acting Reversible Contraception Administration Immediately and Early Postpartum Versus Interval Postpartum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tulane University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tulane University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This a randomized control trial to identify if patients who desire LARC are more likely to
      have success receiving the desired form of contraception if it is placed a) during the
      postpartum hospital stay, either in the immediate or early postpartum period, versus b)
      during the interval postpartum period as previously done.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized control trial with control group receiving LARC at 6 weeks postpartum and the
      study group receiving LARC in the immediate or early postpartum period. Outcomes will be
      measured by those who receive or do not receive LARC either in the hospital after delivery
      versus 6 weeks postpartum in accordance with the study subjects' randomized designation.
      Secondary outcomes of bleeding profile and satisfaction will also be assessed.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date type="Actual">October 22, 2014</start_date>
  <completion_date type="Actual">May 31, 2016</completion_date>
  <primary_completion_date type="Actual">December 21, 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of placing LARC during the immediate or early postpartum period compared to during the interval postpartum period for LARC postpartum contraception methods.</measure>
    <time_frame>6 months</time_frame>
    <description>The outcome will be measured by a ratio. The total number woman who expressed a desire to have postpartum contraception placed and randomized to the appropriate arm will be the denominator. While the numerator will be the total number of women who have postpartum contraception placed per protocol. The two percentages will be compared using a ratio to express the comparison between successful implementation of LARC for postpartum contraception.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction with method of LARC</measure>
    <time_frame>6 months</time_frame>
    <description>Patient satisfaction with LARC will be assessed using a questionnaire aimed at asking the patient how they feel about LARC.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>Immediate or early placement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Immediate or early placement of levonorgestrel IUD, copper IUD, or etonorgestrel sub dermal implant (within 48 hours) postpartum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Interval placement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Interval (4-6 weeks) postpartum placement of levonorgestrel IUD, copper IUD, or etonorgestrel sub dermal implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Levonorgestrel IUD, copper IUD, etonorgestrel implant</intervention_name>
    <description>Long-acting reversible contraception</description>
    <arm_group_label>Immediate or early placement</arm_group_label>
    <arm_group_label>Interval placement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant, desires LARC postpartum

        Exclusion Criteria:

          -  Medical contraindication to desired LARC, vaginal delivery complicated by fourth
             degree perineal laceration, history of pelvic inflammatory disease, uterine infection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sara Junya, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tulane University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tulane Department of Obstetrics and Gynecology</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Brito MB, Ferriani RA, Quintana SM, Yazlle ME, Silva de Sá MF, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception. 2009 Dec;80(6):519-26. doi: 10.1016/j.contraception.2009.05.124. Epub 2009 Jul 10.</citation>
    <PMID>19913145</PMID>
  </results_reference>
  <results_reference>
    <citation>Çelen Ş, Sucak A, Yıldız Y, Danışman N. Immediate postplacental insertion of an intrauterine contraceptive device during cesarean section. Contraception. 2011 Sep;84(3):240-3. doi: 10.1016/j.contraception.2011.01.006. Epub 2011 Feb 21.</citation>
    <PMID>21843687</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen BA, Reeves MF, Hayes JL, Hohmann HL, Perriera LK, Creinin MD. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial. Obstet Gynecol. 2010 Nov;116(5):1079-87. doi: 10.1097/AOG.0b013e3181f73fac.</citation>
    <PMID>20966692</PMID>
  </results_reference>
  <results_reference>
    <citation>Dahlke JD, Terpstra ER, Ramseyer AM, Busch JM, Rieg T, Magann EF. Postpartum insertion of levonorgestrel--intrauterine system at three time periods: a prospective randomized pilot study. Contraception. 2011 Sep;84(3):244-8. doi: 10.1016/j.contraception.2011.01.007. Epub 2011 Feb 24.</citation>
    <PMID>21843688</PMID>
  </results_reference>
  <results_reference>
    <citation>Grimes DA, Lopez LM, Schulz KF, Van Vliet HA, Stanwood NL. Immediate post-partum insertion of intrauterine devices. Cochrane Database Syst Rev. 2010 May 12;(5):CD003036. doi: 10.1002/14651858.CD003036.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;6:CD003036.</citation>
    <PMID>20464722</PMID>
  </results_reference>
  <results_reference>
    <citation>Guazzelli CA, de Queiroz FT, Barbieri M, Torloni MR, de Araujo FF. Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate. Contraception. 2010 Sep;82(3):256-9. doi: 10.1016/j.contraception.2010.02.010. Epub 2010 Mar 29.</citation>
    <PMID>20705154</PMID>
  </results_reference>
  <results_reference>
    <citation>Levi E, Cantillo E, Ades V, Banks E, Murthy A. Immediate postplacental IUD insertion at cesarean delivery: a prospective cohort study. Contraception. 2012 Aug;86(2):102-5. doi: 10.1016/j.contraception.2011.11.019. Epub 2012 Jan 20.</citation>
    <PMID>22264666</PMID>
  </results_reference>
  <results_reference>
    <citation>Shukla M, Qureshi S; Chandrawati. Post-placental intrauterine device insertion--a five year experience at a tertiary care centre in north India. Indian J Med Res. 2012 Sep;136(3):432-5.</citation>
    <PMID>23041736</PMID>
  </results_reference>
  <results_reference>
    <citation>Stuart GS, Bryant AG, O'Neill E, Doherty IA. Feasibility of postpartum placement of the levonorgestrel intrauterine system more than 6 h after vaginal birth. Contraception. 2012 Apr;85(4):359-62. doi: 10.1016/j.contraception.2011.08.005. Epub 2011 Sep 28.</citation>
    <PMID>22067759</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2014</study_first_submitted>
  <study_first_submitted_qc>October 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2017</study_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levonorgestrel</mesh_term>
    <mesh_term>Copper</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

